Menu Search
Equities

Atacadao SA

CRFB3:SAO

Atacadao SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (BRL)6.31
  • Today's Change-0.14 / -2.17%
  • Shares traded16.60m
  • 1 Year change-41.68%
  • Beta0.8197
Data delayed at least 15 minutes, as of Nov 21 2024 22:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform5
Hold8
Sell0
Strong Sell0

Share price forecast in BRL

The 12 analysts offering 12 month price targets for Atacadao SA have a median target of 11.25, with a high estimate of 16.00 and a low estimate of 8.70. The median estimate represents a 78.29% increase from the last price of 6.31.
High153.6%16.00
Med78.3%11.25
Low37.9%8.70

Dividends in BRL

In 2023, Atacadao SA reported a dividend of 0.15 BRL, which represents a 57.32% decrease from last year. The 5 analysts covering the company expect dividends of 0.13 BRL for the upcoming fiscal year, a decrease of 10.67%.
Div growth (TTM)-57.32%
More ▼

Earnings history & estimates in BRL

On Oct 31, 2024, Atacadao SA reported 3rd quarter 2024 earnings of 0.11 per share. This result exceeded the 0.09 consensus of the 4 analysts covering the company and exceeded last year's 3rd quarter results by 83.33%.
The next earnings announcement is expected on Feb 17, 2025.
Average growth rate+334.38%
Atacadao SA reported annual 2023 losses of -0.36 per share on Feb 19, 2024.
Average growth rate+24.11%
More ▼

Revenue history & estimates in BRL

Atacadao S.A. had 3rd quarter 2024 revenues of 28.37bn. This bettered the 26.63bn consensus of the 6 analysts covering the company. This was 9.99% above the prior year's 3rd quarter results.
Average growth rate+1.73%
Atacadao S.A. had revenues for the full year 2023 of 109.85bn. This was 6.77% above the prior year's results.
Average growth rate+16.67%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.